Business Description
![Centene Corp Centene Corp logo](https://static.gurufocus.com/logos/0C0000078O.png?14)
Centene Corp
NAICS : 524114
SIC : 6324
ISIN : US15135B1017
Share Class Description:
CNC: Ordinary SharesCompare
Compare
Traded in other countries / regions
CNC.USA0HVB.UKQEN.Germany1CNC.ItalyCNC.MexicoC1NC34.Brazil IPO Date
2001-12-13Description
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.09 | |||||
Equity-to-Asset | 0.33 | |||||
Debt-to-Equity | 0.67 | |||||
Debt-to-EBITDA | 3.17 | |||||
Interest Coverage | 4.62 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 2.75 | |||||
Beneish M-Score | -2.5 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.7 | |||||
3-Year EBITDA Growth Rate | 7.8 | |||||
3-Year EPS without NRI Growth Rate | 10.1 | |||||
3-Year FCF Growth Rate | 18.4 | |||||
3-Year Book Growth Rate | 2.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | 12.51 | |||||
Future 3-5Y Total Revenue Growth Rate | 4 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.55 | |||||
9-Day RSI | 29.84 | |||||
14-Day RSI | 32.98 | |||||
6-1 Month Momentum % | -1.58 | |||||
12-1 Month Momentum % | 10.02 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.17 | |||||
Quick Ratio | 1.17 | |||||
Cash Ratio | 0.6 | |||||
Days Sales Outstanding | 35.99 | |||||
Days Payable | 33.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 2.8 | |||||
Shareholder Yield % | 10.38 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 11.18 | |||||
Operating Margin % | 2.15 | |||||
Net Margin % | 1.76 | |||||
FCF Margin % | 1.67 | |||||
ROE % | 10.62 | |||||
ROA % | 3.28 | |||||
ROIC % | 3.81 | |||||
ROC (Joel Greenblatt) % | 130.1 | |||||
ROCE % | 8.91 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 13.18 | |||||
Forward PE Ratio | 9.68 | |||||
PE Ratio without NRI | 9.74 | |||||
Shiller PE Ratio | 21.6 | |||||
Price-to-Owner-Earnings | 19.48 | |||||
PEG Ratio | 1.11 | |||||
PS Ratio | 0.23 | |||||
PB Ratio | 1.32 | |||||
Price-to-Tangible-Book | 10.25 | |||||
Price-to-Free-Cash-Flow | 14.01 | |||||
Price-to-Operating-Cash-Flow | 10.92 | |||||
EV-to-EBIT | 7.66 | |||||
EV-to-Forward-EBIT | 9.06 | |||||
EV-to-EBITDA | 5.94 | |||||
EV-to-Forward-EBITDA | 7.29 | |||||
EV-to-Revenue | 0.22 | |||||
EV-to-Forward-Revenue | 0.23 | |||||
EV-to-FCF | 12.95 | |||||
Price-to-Projected-FCF | 0.56 | |||||
Price-to-DCF (Earnings Based) | 0.31 | |||||
Price-to-DCF (FCF Based) | 0.54 | |||||
Price-to-Median-PS-Value | 0.66 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.08 | |||||
Price-to-Graham-Number | 2.11 | |||||
Earnings Yield (Greenblatt) % | 13.05 | |||||
FCF Yield % | 7.36 | |||||
Forward Rate of Return (Yacktman) % | 19.4 |